MicroRNA-124-targeted recombinant Zika virus: a dual-functional and safe candidate for vaccination and oncolytic virotherapy.
Overview
- State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China
- Experimental Platform Management Office, Beijing Key Laboratory of Drug-Resistant Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China
- State Key Laboratory of Proteomics, National Center of Biomedical Analysis, Beijing, China
Abstract
Zika virus (ZIKV) remains a significant public health threat due to its pronounced neurotropism linked to Congenital Zika Syndrome (CZS). Paradoxically, the same neurotropism also provides a unique opportunity for exploiting ZIKV as an oncolytic agent against malignant brain tumors such as glioma. However, achieving precise control of ZIKV replication in specific cell types or tissues remains a major challenge. Here, we show that the brain-specific and enriched microRNA, miR-124, is highly expressed in neural progenitor cells (NPCs) and neurons, but minimally expressed in glioma stem cells (GSCs) and differentiated glioma stem cells (DGCs). Based on these observations, we engineered a recombinant ZIKV containing a miR-124 target sequence (miR-124T) inserted into the 3′ untranslated region (UTR) of the viral genome, generating the virus designated ZIKV-miR124T. ZIKV-miR124T exhibited a significantly attenuated phenotype across multiple mouse models, including adult A129 mice, BALB/
IMPORTANCE: This study presents a crucial advancement in controlling the safety and function of neurotropic viruses. We engineered a dual-purpose ZIKV, ZIKV-miR124T, which is regulated by the brain-specific microRNA, miR-124. This design forces the virus to strongly self-suppress in healthy neural tissue, solving a major safety concern for ZIKV-based therapies. ZIKV-miR124T is shown to be a potent oncolytic agent against malignant glioma while also serving as a highly effective, safe live-attenuated vaccine against ZIKV infection, reducing vertical transmission to the fetus. Our work provides a strong demonstration of utilizing microRNA regulation to achieve precise viral tropism and attenuation, offering a valuable, generalizable strategy for the development of safer and more effective viral therapies and vaccines against neurotropic pathogens.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE331013, at NCBI GEO; found in “DATA AVAILABILITY”
Data availability
Small RNA sequencing data have been deposited in the NCBI GEO database under accession no. GSE331013 (https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 2, 28 September 2026
- Funding: added National Natural Science Foundation of China; National Science and Technology Major Project: 2025ZD01900600; University of California, San Diego
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 15 authors, 5 keywords, 17 MeSH terms, 54 references.
Cite
This paper
Zhou, C., Cheng, M.-L., He, M.-J., Liu, Y., Li, Y.-Y., Xie, D.-Y., Chen, L.-S., Li, D.-Y., Deng, Y.-Q., Xu, Y.-P., Ye, Q., Zhao, H., Li, X.-F., Chen, Q., & Qin, C.-F. (2026). MicroRNA-124-targeted recombinant Zika virus: a dual-functional and safe candidate for vaccination and oncolytic virotherapy. Journal of virology, 100(6), e00208-26. https://
BibTeX
@article{zhou2026microrn
author = {Zhou, Chao and Cheng, Meng-Li and He, Meng-Jiao and Liu, Yao and Li, Yu-Yan and Xie, Dong-Yang and Chen, Li-Shu and Li, De-Yu and Deng, Yong-Qiang and Xu, Yan-Peng and Ye, Qing and Zhao, Hui and Li, Xiao-Feng and Chen, Qi and Qin, Cheng-Feng},
title = {{MicroRNA-124-targeted recombinant Zika virus: a dual-functional and safe candidate for vaccination and oncolytic virotherapy}},
journal = {Journal of virology},
year = {2026},
month = may,
volume = {100},
number = {6},
pages = {e00208--26},
publisher = {American Society for Microbiology (ASM)},
issn = {0022-538X},
doi = {10.1128/
url = {https://
pmid = {42138703},
pmcid = {PMC13288617}
}
RIS
TY - JOUR
AU - Zhou, Chao
AU - Cheng, Meng-Li
AU - He, Meng-Jiao
AU - Liu, Yao
AU - Li, Yu-Yan
AU - Xie, Dong-Yang
AU - Chen, Li-Shu
AU - Li, De-Yu
AU - Deng, Yong-Qiang
AU - Xu, Yan-Peng
AU - Ye, Qing
AU - Zhao, Hui
AU - Li, Xiao-Feng
AU - Chen, Qi
AU - Qin, Cheng-Feng
TI - MicroRNA-124-targeted recombinant Zika virus: a dual-functional and safe candidate for vaccination and oncolytic virotherapy
T2 - Journal of virology
J2 - J Virol
PY - 2026
DA - 2026/
VL - 100
IS - 6
SP - e00208
EP - 26
SN - 0022-538X
PB - American Society for Microbiology (ASM)
DO - 10.1128/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1128/
"type": "article-journal",
"title": "MicroRNA-124-targeted recombinant Zika virus: a dual-functional and safe candidate for vaccination and oncolytic virotherapy",
"container-title": "Journal of virology",
"author": [
{
"family": "Zhou",
"given": "Chao"
},
{
"family": "Cheng",
"given": "Meng-Li"
},
{
"family": "He",
"given": "Meng-Jiao"
},
{
"family": "Liu",
"given": "Yao"
},
{
"family": "Li",
"given": "Yu-Yan"
},
{
"family": "Xie",
"given": "Dong-Yang"
},
{
"family": "Chen",
"given": "Li-Shu"
},
{
"family": "Li",
"given": "De-Yu"
},
{
"family": "Deng",
"given": "Yong-Qiang"
},
{
"family": "Xu",
"given": "Yan-Peng"
},
{
"family": "Ye",
"given": "Qing"
},
{
"family": "Zhao",
"given": "Hui"
},
{
"family": "Li",
"given": "Xiao-Feng"
},
{
"family": "Chen",
"given": "Qi"
},
{
"family": "Qin",
"given": "Cheng-Feng"
}
],
"container-title-short":
"volume": "100",
"issue": "6",
"page": "e00208-26",
"DOI": "10.1128/
"PMID": "42138703",
"PMCID": "PMC13288617",
"ISSN": "0022-538X",
"publisher": "American Society for Microbiology (ASM)",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
15
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1016/j.omto.2022.01.011
- Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma.Journal: Molecular therapy oncolyticsIn common: other condition, mouse, 9 references, author Cheng-Feng Qin
- [2] doi:10.1038/s41598-025-97804-8
- Multi-omics analysis reveals key immunogenic signatures induced by oncolytic Zika virus infection of paediatric brain tumour cells.Journal: Scientific reportsIn common: other condition, cellular / molecular, 7 references
- [3] doi:10.3389/fimmu.2021.721830
- Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas.Journal: Frontiers in immunologyIn common: other condition, 5 references
- [4] doi:10.1016/j.ebiom.2023.104457 [code]
- Zika virus leads to olfactory disorders in mice by targeting olfactory ensheathing cells.Journal: EBioMedicineIn common: other condition, mouse, 1 reference, author Cheng-Feng Qin
- [5] doi:10.1016/j.xcrm.2025.102509
- Intracranial injection of genetically modified, mosquito non-transmissible Zika virus: Safety in primates and ramifications for brain tumor therapy.Journal: Cell reports. MedicineIn common: other condition, 4 references
- [6] doi:10.1038/s41467-025-60228-z
- Elevated nonhomologous end-joining by AATF enables efficient DNA damage repair and therapeutic resistance in glioblastoma.Journal: Nature communicationsIn common: other condition, mouse, cellular / molecular, 3 references
- [7] doi:10.1038/s41467-024-55155-4 [code]
- Epidemic Zika virus strains from the Asian lineage induce an attenuated fetal brain pathogenicity.Journal: Nature communicationsIn common: other condition, mouse, 3 references
- [8] doi:10.1371/journal.pntd.0011657
- Zika virus diversity in mice is maintained during early vertical transmission from placenta to fetus, but reduced in fetal bodies and brains at late stages of infection.Journal: PLoS neglected tropical diseasesIn common: other condition, mouse, 3 references
- [9] doi:10.3390/ijms27114833
- Alterations in the Components of the GABA-Glutamate System During ZIKV Infection: A Neuroscience Approach.Journal: International journal of molecular sciencesIn common: other condition, mouse, cellular / molecular, 3 references
- [10] doi:10.1038/s41467-024-49524-2 [code]
- Disruption of myelin structure and oligodendrocyte maturation in a macaque model of congenital Zika infection.Journal: Nature communicationsIn common: other condition, cellular / molecular, 3 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
